Patrick Link, PhD

Research Project:
Myeloperoxidase Promotes Persistent Fibrosis

Grant Awarded:

Dalsemer Grant

Research Topic:

basic biologic mechanisms

Research Diseases:

interstitial lung disease
pulmonary fibrosis

Pulmonary fibrosis (PF) is a progressive fatal lung disease expected to increase dramatically due to post-COVID complications. In human disease and experimental models, it remains unclear what separates normal wound healing from progressive lung scarring and persistent disease. An enzyme called myeloperoxidase increases in PF and has been correlated with rapid deterioration of pulmonary fibrosis patients. Myeloperoxidase contributes to fibrosis in other major organ systems as well. Whether myeloperoxidase contributes to PF progression and prevents resorption of scar tissue is unknown. We will use laboratory tests and animal models of PF to determine the role of this enzyme in PF and determine if it is a potential target for treatment.

Page last updated: October 3, 2023

Join the Patient & Caregiver Network

End Youth Vaping

10 Tips to Protect Yourself from Unhealthy Air

State of the Air Key Findings

Become an Advocate

Events Near You

Patrick Link, PhD

A Breath of Fresh Air in Your Inbox

Thank You!

Make a Donation

Become a Lung Health Insider

Select Your Location

Change Language

Lung HelpLine

1-800-LUNG-USA